Omeros (OMER) EBITDA Margin (QoQ) (2010 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2,354.00 |
| Jun 30, 2021 | 6,741.00 |
| Mar 31, 2021 | 18,396.00 |
| Dec 31, 2020 | -20,328.00 |
| Sep 30, 2020 | 9,879.00 |
| Jun 30, 2020 | -12,273.00 |
| Mar 31, 2020 | -3,589.00 |
| Dec 31, 2019 | -3,231.00 |
| Sep 30, 2019 | -112.00 |
| Jun 30, 2019 | 5,776.00 |
| Mar 31, 2019 | -489.00 |
| Dec 31, 2018 | 74,971.00 |
| Sep 30, 2018 | 117,941.00 |
| Jun 30, 2018 | -14,344.00 |
| Mar 31, 2018 | -177,229.00 |
| Dec 31, 2017 | -8,574.00 |
| Sep 30, 2017 | 4,917.00 |
| Jun 30, 2017 | 3,938.00 |
| Mar 31, 2017 | 2,902.00 |
| Dec 31, 2016 | -2,845.00 |
| Sep 30, 2016 | 239.00 |
| Jun 30, 2016 | 15,077.00 |
| Mar 31, 2016 | 2,018.00 |
| Dec 31, 2015 | 31,424.00 |
| Sep 30, 2015 | -8,788.00 |
| Jun 30, 2015 | 428,822.00 |
| Mar 31, 2015 | 669,562.00 |
| Dec 31, 2014 | -294,320.00 |
| Sep 30, 2014 | 3.14 Mn |
| Jun 30, 2014 | -2.33 Mn |
| Mar 31, 2014 | -1.56 Mn |
| Dec 31, 2013 | 598,481.00 |
| Sep 30, 2013 | 263,204.00 |
| Jun 30, 2013 | -875,067.00 |
| Mar 31, 2013 | -46,933.00 |
| Dec 31, 2012 | 44,834.00 |
| Sep 30, 2012 | -37,734.00 |
| Jun 30, 2012 | 3,502.00 |
| Mar 31, 2012 | 29,789.00 |
| Dec 31, 2011 | -23,270.00 |
| Sep 30, 2011 | -20,168.00 |
| Jun 30, 2011 | 6,991.00 |
| Mar 31, 2011 | 34,874.00 |
| Dec 31, 2010 | 207,208.00 |
| Sep 30, 2010 | -141,280.00 |